Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.